Abstract:The ontogeny of D1 and D2 dopamine (DA) receptors in rat basal ganglia was examined by quantitative autoradiography using the iodinated ligands [125I]SCH 23982 and [125I]iodobenzamide [( 125I]IBZM), respectively. Temporal and spatial differences in the development of the receptor subtypes were observed. Scatchard transformation of saturation isotherms conducted at postnatal day 10 (P10) and P60, showed that there was no age-related change in the affinity of [125I]SCH 23982 binding to D1 receptors (Kd = 2.6 nM) but there was a significant increase in the Bmax (771 compared to 2032 fmol/mg protein, P = 0.002). A statistically significant difference in Kd was noted between ages P10 and P60 for [125I]IBZM labelling of D2 receptors (0.62 vs 1.00 nM, respectively, P less than 0.01). A significant increase in the Bmax (211 and 721 fmol/mg protein, P less than 0.01) was also observed. D1 receptors were visible as distinct patches at P1. The highest density was found in the ventrolateral caudate-putamen (CPu). By P5 the patches were found in all subregions of the CPu and nucleus accumbens. Between P7 and P10 the binding became distinctly less patchy due to a marked increase in the density of D1 receptors in non-patch (matrix) regions. Adult levels of receptor were seen by P30. The concentration of DA (measured by HPLC) and binding of [3H]mazindol to DA uptake sites in whole striatum showed similar and nonlinear increases with age. The age-related change in the topography of binding sites for [3H]mazindol was similar to that of D1 receptors at the same ages. Both D2 receptors and [3H]hemicholinium-3 (HC-3) binding to high affinity transport sites for choline developed initially in the dorso-lateral CPu. Their topography was largely overlapping but distinct from that of the D1 receptor. D2 receptors were not consistently observed until P3 in the CPu, and zones of enriched binding were aligned with zones of low density for D1 receptors. The density of D2 receptors reached adult levels by P30. The differential development of the DA receptors was also evident in the substantia nigra (SN) and globus pallidus (GP). D1 receptors were found in SN prior to the appearance of D2 receptors and throughout development the density was greater in pars reticulata than in pars compacta, whereas the density of D2 receptors was higher in the pars compacta. At all ages the density of D1 receptors was greater than the density of D2 receptors in the GP and reached adult levels before reaching it in the CPu or SN.(ABSTRACT TRUNCATED AT 400 WORDS)

Pharmacologic Neuroimaging Of The Ontogeny Of Dopamine Receptor Function

Novel pharmacokinetic model to estimate dopamine dynamics in humans using PET

Ontogeny of dopamine D1 and D2 receptor subtypes in rat basal ganglia: a quantitative autoradiographic study

Increased Vesicular Monoamine Transporter 2 (VMAT2) and Dopamine Transporter (DAT) Expression in Adolescent Brain Development: A Longitudinal Micro-PET/CT Study in Rodent

Positron Emission Tomography Molecular Imaging Of Dopaminergic System In Drug Addiction

Insights from Behavioral and Dorsal Raphe Nucleus Neuronal Recordings from Freely Behaving Rats

O10. How Dopamine Receptor Binding Affects Human Brain Networks in Real Time: Preliminary Evidence from Simultaneous PET-fMRI with a Drug Challenge

Ultra‐high‐field pharmacological functional MRI of dopamine D1 receptor‐related interventions in anesthetized rats

Unraveling Dopamine D3 Receptor Function in Response to Psychostimulants Using a Genetic Approach.

Dopamine transporter blockade during adolescence increases adult dopamine function, impulsivity, and aggression

Assessment Of Dopamine D3 Receptor Function Using D3 Receptor Knockout Mice

Dopamine transporter silencing in the rat: systems-level alterations in striato-cerebellar and prefrontal-midbrain circuits

Long-Term Stimulant Treatment Affects Brain Dopamine Transporter Level in Patients with Attention Deficit Hyperactive Disorder

Dopaminergic action beyond its effects on motor function: imaging studies

Differentiation of Non-Pharmacological from Pharmacological Dopamine Release in the Living Human Brain

Adolescent chemogenetic activation of dopaminergic neurons leads to reversible decreases in amphetamine-induced stereotypic behavior

Pharmacological modulation of dopamine D1 and D2 receptors reveals distinct neural networks related to probabilistic learning in non-human primates.

Dissociable Rate-Dependent Effects of Oral Methylphenidate on Impulsivity and D2/3 Receptor Availability in the Striatum

Behavioral responses to cocaine and amphetamine administration in mice lacking the dopamine D1 receptor.

Modulation of High Impulsivity and Attentional Performance in Rats by Selective Direct and Indirect Dopaminergic and Noradrenergic Receptor Agonists

DOPAMAP, high-resolution images of dopamine 1 and 2 receptor expression in developing and adult mouse brains